Recently, among the plethora of identified molecules, growth differentiation factor 15 (GDF15) has been explored in several pre-clinical and clinical studies as a potential biomarker for MASLD [5]. The gene discussed is GDF15; the disease is metabolic dysfunction-associated steatotic liver disease.